$CUTR
CUTERA INC Stock $cutr

$cutr Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000143774920010264 Filed on May 11, 2020

Income Statement

Concept	2020 Q1	2019 Q1	2018 Q4
Revenue	$32.24M	$36.03M	$45.47M
YoY Change	-10.51%	5.57%	-4.54%
Cost Of Revenue	$17.90M	$18.72M	$26.68M
YoY Change	-4.35%	11.47%	31.45%
Gross Profit	$14.34M	$17.31M	$18.79M
YoY Change	-17.18%	-0.14%	-31.27%
Gross Profit Margin	44.47%	48.05%	41.32%
Selling, General & Admin	$22.60M	$21.63M	$20.81M
YoY Change	4.47%	16.74%	7.78%
% of Gross Profit	157.61%	124.96%	110.78%
Research & Development	$3.870M	$3.706M	$3.464M
YoY Change	4.43%	4.22%	-0.49%
% of Gross Profit	26.99%	21.41%	18.44%
Depreciation & Amortization	$360.0K	$411.0K	$360.0K
YoY Change	-12.41%	61.81%	33.33%
% of Gross Profit	2.51%	2.37%	1.92%
Operating Expenses	$26.47M	$25.34M	$24.28M
YoY Change	4.46%	14.73%	6.52%
Operating Profit	-$12.13M	-$8.026M	-$5.490M
YoY Change	51.12%	69.0%	-220.85%
Interest Expense	-$210.0K	-$80.00K	-$40.00K
YoY Change	162.5%	-180.0%	-128.57%
% of Operating Profit
Other Income/Expense, Net	-$207.0K	-$79.00K	-$44.00K
YoY Change	162.03%	-180.61%	-131.88%
Pretax Income	-$12.34M	-$8.105M	-$5.534M
YoY Change	52.2%	74.26%	-218.22%
Income Tax	$78.00K	$115.0K	$20.76M
% Of Pretax Income
Net Earnings	-$12.41M	-$8.220M	-$26.29M
YoY Change	51.02%	304.53%	-214.92%
Net Earnings / Revenue	-38.51%	-22.82%	-57.83%
Basic Earnings Per Share	-$0.86	-$0.59	-$1.89
Diluted Earnings Per Share	-$0.86	-$0.59	-$1.89
COMMON SHARES
Basic Shares Outstanding	14.43M	14.02M	13.93M
Diluted Shares Outstanding	14.43M	14.02M	13.93M

Balance Sheet

Concept	2020 Q1	2019 Q1	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.50M	$27.10M	$35.60M
YoY Change	-28.04%	12.92%	-0.84%
Cash & Equivalents	$14.77M	$19.16M	$26.05M
Short-Term Investments	$4.700M	$7.900M	$9.500M
Other Short-Term Assets	$4.800M	$4.900M	$4.000M
YoY Change	-2.04%	88.46%	37.93%
Inventory	$36.94M	$26.66M	$28.01M
Prepaid Expenses
Receivables	$15.66M	$19.14M	$19.64M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$76.95M	$77.76M	$87.20M
YoY Change	-1.03%	0.44%	-1.33%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.687M	$2.407M	$2.672M
YoY Change	11.63%	8.72%	27.48%
Goodwill	$1.339M	$1.339M	$1.339M
YoY Change	0.0%	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.901M	$5.960M	$5.971M
YoY Change	-0.99%	11.05%	1496.52%
Total Long-Term Assets	$17.48M	$19.60M	$10.44M
YoY Change	-10.82%	-36.18%	-54.34%
TOTAL ASSETS
Total Short-Term Assets	$76.95M	$77.76M	$87.20M
Total Long-Term Assets	$17.48M	$19.60M	$10.44M
Total Assets	$94.43M	$97.36M	$97.64M
YoY Change	-3.0%	-9.96%	-12.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.60M	$10.34M	$11.28M
YoY Change	41.28%	25.97%	61.08%
Accrued Expenses	$23.66M	$21.79M	$23.30M
YoY Change	8.61%	8.49%	-13.22%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$500.0K	$600.0K
YoY Change	-16.67%
Total Short-Term Liabilities	$52.42M	$46.90M	$47.62M
YoY Change	11.77%	26.28%	9.95%
LONG-TERM LIABILITIES
Long-Term Debt	$400.0K	$400.0K	$0.00
YoY Change	0.0%
Other Long-Term Liabilities	$447.0K	$0.00	$140.0K
YoY Change		-100.0%	-69.57%
Total Long-Term Liabilities	$447.0K	$0.00	$140.0K
YoY Change		-100.0%	-69.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$52.42M	$46.90M	$47.62M
Total Long-Term Liabilities	$447.0K	$0.00	$140.0K
Total Liabilities	$60.89M	$58.24M	$51.25M
YoY Change	4.57%	44.61%	10.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.77M	-$32.23M	-$24.01M
YoY Change	51.32%	-647.38%	-914.73%
Common Stock	$82.31M	$71.41M	$70.47M
YoY Change	15.25%	15.05%	13.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.54M	$39.12M	$46.39M
YoY Change
Total Liabilities & Shareholders Equity	$94.43M	$97.36M	$97.64M
YoY Change	-3.0%	-9.96%	-12.23%

Cashflow Statement

Concept	2020 Q1	2019 Q1	2018 Q4
OPERATING ACTIVITIES
Net Income	-$12.41M	-$8.220M	-$26.29M
YoY Change	51.02%	304.53%	-214.92%
Depreciation, Depletion And Amortization	$360.0K	$411.0K	$360.0K
YoY Change	-12.41%	61.81%	33.33%
Cash From Operating Activities	-$11.97M	-$7.953M	$8.430M
YoY Change	50.46%	-20.84%	26.2%
INVESTING ACTIVITIES
Capital Expenditures	$230.0K	$65.00K	-$280.0K
YoY Change	253.85%	-37.5%	-33.33%
Acquisitions
YoY Change
Other Investing Activities	$2.870M	$1.610M	-$4.490M
YoY Change	78.26%	-81.39%	-132.33%
Cash From Investing Activities	$2.640M	$1.549M	-$4.760M
YoY Change	70.43%	-81.88%	-135.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.216M	-490.0K	520.0K
YoY Change	352.24%	-72.43%	-102.51%
NET CHANGE
Cash From Operating Activities	-$11.97M	-7.953M	8.430M
Cash From Investing Activities	$2.640M	1.549M	-4.760M
Cash From Financing Activities	-$2.216M	-490.0K	520.0K
Net Change In Cash	-$11.54M	-6.894M	4.190M
YoY Change	67.42%	110.57%	-798.33%
FREE CASH FLOW
Cash From Operating Activities	-$11.97M	-$7.953M	$8.430M
Capital Expenditures	$230.0K	$65.00K	-$280.0K
Free Cash Flow	-$12.20M	-$8.018M	$8.710M
YoY Change	52.11%	-21.01%	22.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5000
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6567000
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1467000
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1253000
CY2019Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	525000
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3020000
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1355000
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	207000
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	679000
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-140000
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-807000
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	916000
CY2020Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14688000
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13970000
CY2020Q1	us-gaap	Inventory Net InventoryNet	36941000
CY2019Q4	us-gaap	Inventory Net InventoryNet	33921000
CY2020Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19092000
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	17935000
CY2020Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	3161000
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2016000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-8220000
CY2019Q4	us-gaap	Litigation Reserve LitigationReserve	0
CY2020Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4746000
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7605000
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	43.91
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	295699
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	253848
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2216000
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-490000
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2640000
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1549000
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11966000
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7953000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-12414000
CY2020Q1	us-gaap	Liabilities Liabilities	60894000
CY2019Q4	us-gaap	Liabilities Liabilities	67796000
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	94430000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	113738000
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	52416000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	58622000
CY2020Q1	us-gaap	Litigation Reserve LitigationReserve	0
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-207000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.52
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	26465000
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	25335000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12129000
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-79000
CY2020Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-61000
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8026000
CY2020Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	728000
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	7353000
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2204000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2800000
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5149000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5112000
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	727000
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7143000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7702000
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.044
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y292D
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5399000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5116000
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5901000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6411000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
CY2019Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	6000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	61000
CY2019Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	6000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	61000
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6000
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	490000
CY2020Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	3930000
CY2019Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1586000
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	230000
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	65000
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	447000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	578000
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	35000
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	103000
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2234000
CY2020Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1443000
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	98000
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3870000
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4831000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5648000
CY2020Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	201000
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3706000
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48772000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36358000
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	32239000
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	36026000
CY2019Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	131000
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	6800000
CY2019Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	3200000
CY2020Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3398000
CY2019Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4401000
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2687000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2817000
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	590000
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	12900000
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.78
CY2019Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	3922000
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14789000
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	16104000
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1980000
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1307000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	761705
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	690379
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	19560
CY2020Q1	cutr	Reduction In Salaries Of Employees And Furloughs In Response To Covid19 Outbreak Percentage Of Workforce ReductionInSalariesOfEmployeesAndFurloughsInResponseToCovid19OutbreakPercentageOfWorkforce	0.42
CY2019Q4	cutr	Debt Securities Availableforsale Net Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableforsaleNetAccumulatedGrossUnrealizedGainLossBeforeTax	0
CY2020Q1	cutr	Deferred Revenue Costs Incurred DeferredRevenueCostsIncurred	2200000
CY2019Q1	cutr	Deferred Revenue Costs Incurred DeferredRevenueCostsIncurred	2000000
CY2020Q1	cutr	Accrued Sales And Marketing Costs Current AccruedSalesAndMarketingCostsCurrent	1581000
CY2019Q4	cutr	Accrued Sales And Marketing Costs Current AccruedSalesAndMarketingCostsCurrent	2527000
CY2020Q1	cutr	Available For Sale Securities Debt Maturities Year Two Through Three Fair Value AvailableForSaleSecuritiesDebtMaturitiesYearTwoThroughThreeFairValue
CY2020Q1	cutr	Available For Sale Securities Including Restricted Investments AvailableForSaleSecuritiesIncludingRestrictedInvestments	4746000
CY2020Q1	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	2058000
CY2019Q1	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	3173000
CY2020Q1	cutr	Debt Securities Availableforsale Net Accumulated Gross Unrealized Gain Loss Before Tax DebtSecuritiesAvailableforsaleNetAccumulatedGrossUnrealizedGainLossBeforeTax	1000
CY2020Q1	cutr	Increase Decrease In Extended Product Warranty Accrual IncreaseDecreaseInExtendedProductWarrantyAccrual	-234000
CY2019Q1	cutr	Increase Decrease In Extended Product Warranty Accrual IncreaseDecreaseInExtendedProductWarrantyAccrual	-492000
CY2020Q1	cutr	Lease Rightofuse Asset LeaseRightofuseAsset	8002000
CY2020Q1	cutr	Reduction In Board Of Directors Fees In Response To Covid19 Outbreak Percentage ReductionInBoardOfDirectorsFeesInResponseToCOVID19OutbreakPercentage	0.25
CY2020Q1	cutr	Reduction In Salaries Of Chief Executive Officer President Chief Operating Officer And Some Managers In Response To Covid19 Outbreak Percentage ReductionInSalariesOfChiefExecutiveOfficerPresidentChiefOperatingOfficerAndSomeManagersInResponseToCovid19OutbreakPercentage	0.25
CY2020Q1	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	343911
CY2020Q1	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	434797
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001162461
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	17463025
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	CUTERA INC
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock ($0.001 par value)
CY2020Q1	dei	Trading Symbol TradingSymbol	cutr
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	14604000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12685000
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15660000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21556000
CY2020Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	93000
CY2019Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	93000
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23663000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30307000
CY2020Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	11842000
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	14341000
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-60000
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82292000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	82346000
CY2020Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	717000
CY2019Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	690000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1980000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1307000
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1980000
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1307000
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	937000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1354000
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1007000
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1232000
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	938000
CY2020Q1	us-gaap	Assets Assets	94430000
CY2019Q4	us-gaap	Assets Assets	113738000
CY2020Q1	us-gaap	Assets Current AssetsCurrent	76952000
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Assets Current AssetsCurrent	95046000
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	19519000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	33921000
CY2020Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	4746000
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	19520000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	33921000
CY2020Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred
CY2019Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	192000
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14774000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26316000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26052000
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19158000
CY2020Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11542000
CY2019Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6894000
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14578146
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14315586
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14578146
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14315586
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	15000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	14000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12353000
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8214000
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17903000
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18717000
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	408000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	423000
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	15000
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000
CY2019Q4	us-gaap	Deferred Revenue DeferredRevenue	14222000
CY2018Q4	us-gaap	Deferred Revenue DeferredRevenue	12566000
CY2020Q1	us-gaap	Deferred Revenue DeferredRevenue	12969000
CY2019Q1	us-gaap	Deferred Revenue DeferredRevenue	13090000
CY2020Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10180000
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10831000
CY2020Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	2789000
CY2019Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3391000
CY2020Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	3312000
CY2019Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	2649000
CY2020Q1	us-gaap	Depreciation Depreciation	360000
CY2019Q1	us-gaap	Depreciation Depreciation	411000
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.86
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	18300000
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y244D
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5306000
CY2019Q4	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	1999000
CY2020Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	19000
CY2020Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	19000
CY2020Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	988000
CY2018Q4	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	3200000
CY2020Q1	us-gaap	Extended Product Warranty Accrual Current ExtendedProductWarrantyAccrualCurrent	1765000
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	541000
CY2020Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	447000
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	183000
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	131000
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	149000
CY2020Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.056
CY2020Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y182D
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7806000
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5525000
CY2020Q1	us-gaap	Goodwill Goodwill	1339000
CY2019Q4	us-gaap	Goodwill Goodwill	1339000
CY2020Q1	us-gaap	Gross Profit GrossProfit	14336000
CY2019Q1	us-gaap	Gross Profit GrossProfit	17309000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12336000
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-8105000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	78000
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	115000
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1919000
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-942000
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-403000
CY2020Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2019Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14433000
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14017000
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14433
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.55
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	8.98
CY2019Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4401000
CY2018Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4666000
CY2020Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3398000
CY2019Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4064000
CY2020Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1863000
CY2019Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	2048000
CY2020Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	860000
CY2019Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1444000
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	22291
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2233000
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-490000
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	200000
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	131000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	33536000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	45942000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	46386000
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	39120000
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates. </div> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </div> <div style=" margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commission, allowance for credit losses, and sales allowances, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived-assets, incremental borrowing rates related to the Company’s leases, assumptions regarding variables used in calculating the fair value of the Company's equity awards, expected achievement of performance based vesting criteria, management performance bonuses, fair value of investments, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable consideration, contingent liabilities, recoverability of deferred tax assets, and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</div></div></div>
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14017
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14433000
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14017000

Files In Submission

Name	View Source	Status
0001437749-20-010264-index-headers.html	Edgar Link	pending
0001437749-20-010264-index.html	Edgar Link	pending
0001437749-20-010264.txt	Edgar Link	pending
0001437749-20-010264-xbrl.zip	Edgar Link	pending
cutr-20200331.xml	Edgar Link	completed
cutr-20200331.xsd	Edgar Link	pending
cutr-20200331_cal.xml	Edgar Link	unprocessable
cutr-20200331_def.xml	Edgar Link	unprocessable
cutr-20200331_lab.xml	Edgar Link	unprocessable
cutr-20200331_pre.xml	Edgar Link	unprocessable
cutr20200331_10q.htm	Edgar Link	pending
ex_182946.htm	Edgar Link	pending
ex_182947.htm	Edgar Link	pending
ex_182948.htm	Edgar Link	pending
ex_183347.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CUTR
CUTERA INC Stock $cutr

2020 Q1 Form 10-Q Financial Statement

#000143774920010264 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR CUTERA INC Stock $cutr

2020 Q1 Form 10-Q Financial Statement

#000143774920010264 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR
CUTERA INC Stock $cutr